ClinicalTrials.Veeva

Menu
S

Santa Familia Centrum Badan, Profilaktyki I Leczenia | Lodz, Poland

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Vedolizumab
RPC1063
ABX464
EMPagliflozin
Apixaban
BI 690517
Adalimumab
695501
BI 695501
Empagliflozin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 15 total trials

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Active, not recruiting
Atrial Fibrillation
Drug: Apixaban Placebo
Drug: Milvexian

This study is being conducted to establish the efficacy of ruxolitinib cream in participants with moderate AD who had an inadequate response to, or a...

Enrolling
Atopic Dermatitis
Drug: Ruxolitinib Cream
Drug: Vehicle Cream

This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left...

Enrolling
Heart Failure
Drug: vicadrostat
Drug: Empagliflozin

Trial sponsors

Boehringer Ingelheim logo
Takeda logo
A
Celgene logo
Incyte logo
Janssen (J&J Innovative Medicine) logo
Novo Nordisk logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems